Question: What is the top priority of the company that was formerly known as EyeTech Pharmaceuticals?
Sentence (from "OSI Pharmaceuticals"): OSI has also made a foray into the ophthalmology market through a marketing agreement with Pfizer over Macugen (Pegaptanib) for Age-related macular degeneration; however, acquisition of the firm Eyetech, meant to provide control over this product and diversify the company, has been unsuccessful, ending in divestiture.
Relevant evidence: No